GOLDCREST

Silvercrest reported Q3 2025 EPS of $0.19 versus an expected $0.28 (−32.1%) and revenue of $31.3 million compared with $32.25 million expected. Expenses rose 15.4%, and assets under management reached a new high of $37.6 billion. The stock was unchanged after hours at $14.34; management expects further AUM growth and a return to previous EBITDA margins. » More on de.investing.com

GOLDCREST is expected to release its quarterly results for September 30, 2025, on October 31, 2025. One analyst forecasts earnings per share of 19.70 JPY, a decline of 45.69% from 36.27 JPY a year earlier. Two analysts expect average quarterly revenue of 6.17 billion JPY, a decrease of 11.41% from 6.97 billion JPY a year earlier. For the current fiscal year, two analysts on average forecast earnings per share of 155.45 JPY and revenue of 30.45 billion JPY. » More on finanzen.net

Merit Medical’s Embosphere microspheres have been approved in the EU for use in genicular artery embolization (GAE) to treat knee osteoarthritis. In the GENESIS study, more than 75% of patients treated with Embosphere achieved clinical success with significant pain relief lasting up to 24 months, along with reduced analgesic use and improved quality of life. The expanded indication complements existing Embosphere applications and follows strong quarterly results from Merit Medical that exceeded analysts’ estimates. » More on de.investing.com

Hong Kong-based Skyline Builders Group Holding Limited reports a private placement of around USD 17.8m through the issuance of up to 24.35m class A shares and warrants; about USD 7m are intended for the repurchase of 18.5m shares from Supreme Development (BVI) Holdings Limited. According to InvestingPro, the company has a weak balance sheet with high debt, heavy cash outflows and high stock volatility; co-placement agents are Dominari Securities LLC, Revere Securities LLC and Pacific Century Securities. Skyline is seeking certain Cayman Islands governance exemptions under NASDAQ rules and is planning a possible 10-for-1 share consolidation, which still requires shareholder approval. » More on de.investing.com

Moody's has downgraded Champion REIT's Corporate Family Rating to Ba1 and withdrawn the issuer rating; the rating of subsidiary Champion MTN Limited was also lowered to (P)Ba1. The agency expects declining adjusted EBITDA and a deterioration in leverage metrics due to persistent oversupply in Hong Kong's office market, but sees sufficient liquidity for the next 12 months and a stable outlook. » More on de.investing.com